President, Telix Japan

Mr. Nishimura has over 25 years of experience in researching and developing molecular imaging agents in Japan and around the world.

Prior to joining Telix, Shintaro held key roles at Astellas Pharma Inc., Eli Lilly Japan KK and ImaginAb Japan KK where he led the development of molecular imaging drugs. Earlier in his career he gained significant experience developing automated radiochemistry systems, and PET image analysis tools and has directed translational imaging studies globally.

Shintaro holds a PhD in applied chemistry from Keio University and was post-doctoral fellow at University of Michigan Medical School.